Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.
Journal: bioRxiv : the preprint server for biology
Published: March 18, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.
Journal: British journal of cancer
Published: February 04, 2026
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.
Journal: Cancers
Published: January 29, 2026
Paediatric therapeutic development workshop on medulloblastoma.
Journal: British journal of cancer
Published: December 13, 2025
Proteasome Cap Targeting Chimeras for Ubiquitination-Independent Targeted Protein Degradation.
Journal: Angewandte Chemie (International ed. in English)
Published: September 11, 2025
KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastoma.
Journal: bioRxiv : the preprint server for biology
Published: July 09, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Journal: Pediatric blood & cancer
Published: February 26, 2025
Insights on Future Directions in Cancer Research from the 2025 AACR NextGen Stars.
Journal: Cancer discovery
Published: February 04, 2025
Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma.
Journal: Frontiers in cell and developmental biology
Published: November 01, 2024
Dominant clones leverage developmental epigenomic states to drive ependymoma.
Journal: Nature
Published: August 09, 2024
Lineage-Selective Dependencies in Pediatric Cancers.
Journal: Cold Spring Harbor perspectives in medicine
Published: May 28, 2024
Last Updated: 09/26/2026